A significant advance in cancer research is occurring with the use of nanobodies to re-engage damaged p53. This vital malignant suppressor protein is frequently inactivated in several types of malignancies, resulting https://ztndz.com/story29825964/vhh-fragments-restore-the-p53-protein-a-promising-approach-for-tumor-management